the regions. Careful estimation for raw material purchasing and production cost management is seriously needed in order to cope with the more dynamic business environment. The raw material reference
for the global steel industry participants in all the regions. Careful estimation for raw material purchasing and production cost management is seriously needed in order to cope with the more dynamic
estimated future returns with reference to the following information: (a) reasonable information used for a factor of estimation; (b) risk factors arising from each condition of estimation; and (c
(UNOFFICIAL TRANSLATION) Codified up to No.9 As of 20 February 2017 Readers should be aware that only the original Thai text has legal force and that this English translation is strictly for reference. Notification of the Capital Market Supervisory Board No. TorThor. 35/2556 Re: Standard Conduct of Business, Management Arrangement, Operating Systems, and Providing Services to Clients of Securities Companies and Derivatives Intermediaries _____________________________ By virtue of Section 16/6 an...
still lack of feasibility and details. Nevertheless, to minimize the risk incurred to the Company and the fixed cost paid monthly, the Company and the shareholders of Blue Finix came to the conclusion to
)% Acquisition cost & pre-operative expense (3) (2) (1) (9) (3) 207% Gain on Bargain Purchases, impairments and feasibility study (Net)* (0) - 74 4 154 (97)% Other Extraordinary Income/(Expense) 0 1 (2) 18 (3
that the discounted cash flow basis is the most appropriate method for assessing the value of Hero Experience. As a result of feasibility study, the Company will execute บมจ.0107537002109 บริษทั ดีมีเตอร
that the discounted cash flow basis is the most appropriate method for assessing the value of Hero Experience. As a result of feasibility study, the Company will execute the transaction by aiming that
income/(expense) (40) (3) 12 (39) 163 Acquisition cost & pre-operative expense (4) (3) (0) (12) (3) 312% Gain on Bargain Purchases, impairments and feasibility study (Net)* (35) (0) 13 (44) 169 Other